XML 85 R75.htm IDEA: XBRL DOCUMENT v3.22.2
Stock Options and Restricted Stock - Summary of Activity for Restricted Stock Programs (Detail) - $ / shares
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Grant price per share, cancelled, lower limit $ 4.89 $ 4.89      
Grant price per share, cancelled, upper limit $ 7.25 $ 7.25      
Restricted Shares [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares, beginning balance 745,270 [1] 493,326 [1] 493,326 [1] 416,140 416,140
Number of shares, granted   383,925 383,925 163,561 258,120
Number of shares, cancelled (583) (5,747)     (21,940)
Number of shares, vested [2]   (126,234)     (158,994)
Number of shares, ending balance [1] 744,687 745,270 744,687   493,326
Grant price per share, lower range limit beginning balance $ 4.89 [1] $ 4.89 [1] $ 4.89 [1] $ 4.39 $ 4.39
Grant price per share, upper range limit beginning balance 8.40 [1] 8.40 [1] 8.40 [1] 7.25 7.25
Grant price per share, granted, lower limit         6.79
Grant price per share, granted, upper limit   7.68     8.40
Grant price per share, cancelled, lower limit 4.89 4.89     4.89
Grant price per share, cancelled, upper limit 8.40 8.40     7.25
Grant price per share, vested, lower limit [2]   4.89     4.39
Grant price per share, vested, upper limit [2]   7.25     7.25
Grant price per share, lower range limit ending balance [1] 4.89 4.89 4.89   4.89
Grant price per share, upper range limit ending balance [1] 8.40 8.40 8.40   8.40
Weighted average grant price beginning balance 7.34 [1] 6.87 [1] 6.87 [1] $ 6.24 6.24
Weighted average grant price, granted   7.68     7.38
Weighted average grant price, cancelled 7.58 7.33     5.98
Weighted average grant price, vested [2]   6.55     6.16
Weighted average grant price, ending balance [1] $ 7.34 $ 7.34 $ 7.34   $ 6.87
[1] The aggregate fair value of the restricted stock was $4.8 million as of June 30, 2022. The remaining vesting period was 2.7 years at June 30, 2022.
[2] The aggregate fair value of the restricted stock vested was $0 and $1.0 million for the three and six months ended June 30, 2022 and was $0 and $0.8 million for the three and six months ended June 30, 2021.